239 results
·
18ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: Eu Ivd General
×
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
LYMPHOKINES /IMMUNMODULATORS - OTHER
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market
ANTIBODIES FOR SUBTYPING OF LEUKEMIA (EXCEPT B-&T-CELL TYPING)
Device
EU IVDD
·
Eu Ivd General
·Agilent Biosciences (Hangzhou) Co., Ltd.·On the market